beta-D-Galp-(1->4)-[alpha-L-Rhap-(1->3)]-beta-D-Glcp-OMe

Term ID

CHEBI:145722

Synonyms

alpha-L-Rha-(1->3)-[beta-D-Gal-(1->4)]-beta-D-Glc-OMe
beta-D-Gal-(1->4)-[alpha-L-Rha-(1->3)]-beta-D-Glc-OMe
Galbeta1-4(Rhaalpha1-3)GlcbetaOMe
methyl 6-deoxy-alpha-L-mannopyranosyl-(1->3)-[beta-D-galactopyranosyl-(1->4)]-beta-D-glucopyranoside
methyl alpha-L-rhamnosyl-(1->3)-[beta-D-galactosyl-(1->4)]-beta-D-glucoside
methyl beta-D-galactopyranosyl-(1->4)-[alpha-L-rhamnopyranosyl-(1->3)]-beta-D-glucopyranoside
methyl beta-D-galactosyl-(1->4)-[alpha-L-rhamnosyl-(1->3)]-beta-D-glucoside
Rhaalpha1-3(Galbeta1-4)GlcbetaOMe
RhaLecOMe

Definition

A methyl glycoside that is beta-D-Galp-(1->4)-[alpha-L-Rhap-(1->3)]-beta-D-Glcp (RhaLac) in which the hydroxy group at the reducing-end anomeric centre is methylated.

References

PMID:31666308

Ontology

ChEBI ( EBI )

Relationships

is a type of: methyl glycoside trisaccharide derivative

methyl glycoside trisaccharide derivative Show first 5 Terms

Phenotype

Phenotype resulting from beta-D-Galp-(1->4)-[alpha-L-Rhap-(1->3)]-beta-D-Glcp-OMe

Phenotype where environments contain beta-D-Galp-(1->4)-[alpha-L-Rhap-(1->3)]-beta-D-Glcp-OMe

Phenotype modified by environments containing beta-D-Galp-(1->4)-[alpha-L-Rhap-(1->3)]-beta-D-Glcp-OMe

Human Disease Model